LIBRARY

Vol. 7, Issue 1

Volume 7, Issue 1

Pages 1–2

PDF
EDITORIAL
JOURNAL

Start of the Seventh Volume in 2023 and Analysis of Publishing Achievements of 2022

Oleksii O. Tymofieieva, Ievgen I. Fesenkob more
a Oleksii O. Tymofieiev

Chief Editor, JDTOMP, Kyiv, Ukraine.

b Ievgen I. Fesenko

Managing Editor, JDTOMP, Kyiv, Ukraine. Corresponding author’s address: Editorial office, Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology (JDTOMP). 13-A Simferopolska Street, Kyiv 02096, Ukraine. E-mail: i.i.fesenko@dtjournal.org (Ievgen Fesenko)

January 14, 2023

J Diagn Treat Oral Maxillofac Pathol 2023;7: 1–2.

Under a Creative Commons license

HOW TO CITE THIS ARTICLE

Tymofieiev OO, Fesenko II. Start of seventh volume in 2023 and analysis of publishing achievements of 2022. J Diagn Treat Oral Maxillofac Pathol 2023;7(1):1–2. https://doi.org/10.23999/j.dtomp.2023.1.1 

 

Article

Starting the 7th volume of the Journal of Diagnostics and Treatment of Oral and Maxillofacial Pathology we are becoming stronger, more mature, and resilient. Even though the Journal has been published for essentially 11 months of 2022 of large-scale war of Russia against Ukraine and Europe, the editorial and publishing staff demonstrated the ability to withstand the impact of war and continue to publish peer-reviewed achievements. In total, 32 articles were published in the volume 6. Among which, 10 articles were devoted to wartime challenges and gunshot wounds.1,2

 

Two papers presented cutting-edge microvascular and prosthetic techniques. Massarelli and Meloni reported a unique technique in a paper titled The “beveled one-and-a-half-barrel” fibula transplant with virtual surgical planning and CT-guided implant surgery for prosthetic rehabilitation in posterior mandible defects: a pictorial essay.3 Le and colleagues manufactured an exclusive tongue prosthesis which was well-described in an article titled Patient-specific prosthetic appliance for interim management of chronic orocutaneous fistula in the irradiated and vessel-depleted head and neck patient – a case report and technical note.4

 

Geographical distribution of authors in 2022 included five countries—Italy, Slovak Republic, Qatar, Ukraine, and United States of America (USA).

 

The first quarter of year 2022 was also marked by the establishment of the resident ambassador position and the appointment of John M. Le, DDS, MD, as a real leader, to this founding position.5 Also, we were honored to see Michael T. Kase, DMD, a true expert in maxillofacial prosthetics as a new board member who can bring a lot of expertise to the Journal in this growing direction.6 Thus, by the end of 2022, the Journal’s editorial board has grown to 30 experts, enhancing Journal’s international vision and approaches.

 

Among all 6,655 users of the Journal website in 2022, in 33.66 percent of cases the users were from USA, in 7.71 percent – from India, in 7.26 percent – from Ukraine, and 51.37 percent from other states. According to Google Analytics of the website https://dtjournal.org, the users were considered as persons who have initiated at least one session during the date range (January 1, 2022 – December 31, 2022).

 

The year 2022 was also marked by the stabilization of the article publishing charge at the competitive level of $500 US and $250 US, depending on the articles’ type. Such step will help publisher to preserve publishing quality, absorb and implement new publishing technologies, and to develop the Journal platform more dynamically, which in turn will increase the visibility of articles and, as a result, contribute to the growth of their citations. We deeply believe that the potentiated sum of the above advantages in combination with rigorous peer-reviewing, hard work, and editorial harmony will allow us to achieve such Journal goals as coverage by PubMed, Scopus, and obtain first impact factor.

 

Summing up the year 2022, we would like to express our deep gratitude to the Armed Forces of Ukraine, which protect not only Ukraine, but also the whole world of free Europe, and make the existence and growth of our Journal possible.

 

Victoria Concordia Crescit [Latin].

 

Victory grows out of harmony.

 

Motto of the Arsenal Football Club

 

 

REFERENCES (6)

  1. Nagorniak IV. Managing private practice in a war zone. J Diagn Treat Oral Maxillofac Pathol 2022;6(3):35–6. Crossref

  2. Shamova TO, Blyzniuk VP. Gunshot fracture of the mandible. J Diagn Treat Oral Maxillofac Pathol 2022;6(4):65–6. Crossref

  3. Massarelli O, Meloni SM. The “beveled one-and-a-half-barrel” fibula transplant with virtual surgical planning and CT-guided implant surgery for prosthetic rehabilitation in posterior mandible defects: a pictorial essay. J Diagn Treat Oral Maxillofac Pathol 2022;6(3):39–59. Crossref

  4. Le JM, Murdock K, Kase MT. Patient-specific prosthetic appliance for interim management of chronic orocutaneous fistula in the irradiated and vessel-depleted head and neck patient – a case report and technical note. J Diagn Treat Oral Maxillofac Pathol 2022;6(12):148–57. Crossref

  5. Tymofieiev OO, Fesenko II. Meet the founding resident ambassador: John M. Le, DDS, MD. J Diagn Treat Oral Maxillofac Pathol 2022;6(1):3–5. Crossref

  6. Tymofieiev OO, Fesenko II. Making a digital editorial bridge between Birmingham, Alabama and Kyiv stronger. J Diagn Treat Oral Maxillofac Pathol 2022;6(8):111–3. Crossref